Navigation Links
Luis Tiant and Sunridge International Partner to Provide Medical Relief in Cuba: Former Star Pitcher for the Red Sox and Yankees Leads the Fight Against Glaucoma
Date:2/2/2010

FOUNTAIN HILLS, Ariz., Feb. 2 /PRNewswire-FirstCall/ -- Sunridge International (OTC Bulletin Board: SNDZ), an innovative developer of safe and noninvasive therapies for glaucoma, proudly announces its partnership with Luis Tiant and Scientific Social Solutions Charitable Foundation (S3) to provide medical relief in Cuba. Tiant, a Cuban native and former starting pitcher for the Boston Red Sox and New York Yankees, will work in conjunction with the Scientific Social Solutions Charitable Foundation and Ophthalmic International (www.oi-pnt.com), a wholly owned subsidiary of Sunridge, to help Cubans fight glaucoma.

Sunridge will send a medical team to Cuba to train doctors and treat patients, followed by a shipment of supplies to a distribution center to help patients after the team leaves the island. Glaucoma is the 2nd leading cause of blindness in Cuba, an issue Mr. Tiant will promote as the spokesperson for this charity drive.

Ophthalmic International has pioneered Pneumatic Trabeculoplasty (PNT), a two-minute, noninvasive, cost effective, alternative treatment for glaucoma. This treatment is ideal for Cuba and other countries' national health care systems because PNT is safe; and the treatment lasts 3-4 months before another round of care is necessary.  

"I'm very excited about being a partner with Sunridge and Ophthalmic International in this medical relief program for Cuba. I know that glaucoma is an incredibly serious problem not only in Cuba but everywhere, and it is always good to be able to give something back," states Luis Tiant.

Credibility and Success Worldwide: Sunridge International in Action

Sunridge International continues to champion PNT and combat glaucoma. "We're extremely pleased with our involvement with Luis Tiant and this project. It will not only help the citizens of Cuba, but will most likely start a domino effect in the Caribbean, because of the fact that 'PNT' provides a safe, affordable and effective treatment for glaucoma patients everywhere," says G. Richard Smith, President and CEO of Sunridge International.

About Sunridge International

Headquartered in Fountain Hills, Arizona, Sunridge International (www.sunridgeint.com) is an innovative developer of Pneumatic Trabeculoplasty (PNT), a safe, noninvasive therapy for glaucoma. Through its wholly owned subsidiary, Ophthalmic International, the company manufactures a vacuum fixation device and a patented design suction ring for the treatment of open angle glaucoma.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.  Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission.

Contact: Jeff Smith, +1-480-837-6165, info@sunridgeint.com

SOURCE Sunridge International

RELATED LINKS
http://www.sunridgeint.com

'/>"/>

SOURCE Sunridge International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... In an article published April 16th on ... Botox and lip injections, which she underwent in order to feel more at home ... Arts Festival. The article explains that Ms. Mirmelli’s situation is not unique; many plastic ...
(Date:4/29/2016)... , ... April 29, 2016 , ... On Tuesday, April ... across the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the ... Duncan (R - Cumming), offers a 70% tax credit to individuals and corporations which ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Coast Dental Fort ... 2016, at its new location in the Exchange Furniture Mall at 112 Vilseck Road ... a 50-inch Samsung Smart TV. Plus attendees will have the opportunity to meet general ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... of patented products, announces the Gyrociser, an exercise invention which aids in proper ... billion," says Scott Cooper, CEO and Creative Director of World Patent Marketing. "Globalization ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... Tie-up with Government hospitals as ... to save newborns   Fortis La Femme, ... collaboration with Breast Milk Foundation (BMF), a non-profit organization within ... Bank, ,Amaara, in Delhi-NCR today. This non-profit centre recognizes that ... and should be available to babies deprived of mother,s milk.  ...
(Date:4/27/2016)... Shire plc (LSE: SHP, NASDAQ: ... Financial Officer, will present at the Deutsche Bank 41st Annual ... on Wednesday, May 04, 2016, 10:00 am EDT (15:00 BST). ... the Presentations and Webcasts section of Shire,s Investor website at ... be available on this same website for approximately 90 days. ...
(Date:4/27/2016)... , April 27, 2016 ... ), a developer of a new generation of ... positive overall survival results for Paclical/Apealea in the ... 789 patients with epithelial ovarian cancer. These preliminary ... Paclical/Apealea in combination with carboplatin versus Taxol in ...
Breaking Medicine Technology: